Diagnostic and exfoliative cytology has today achieved a status that few could have envisaged 20 years ago. While exfoliative cytology has long been employed in gynecological diagnosis, new and rewarding spheres have now developed in which cytological diagnosis plays an important role. Exfoliative cytology, for example, is widely employed as an aid in the continuous assessment of urinary tract tumors, and aspiration cytology in the diagnosis of thyroid dis eases. This has given rise to a growing demand for pathologists experienced in cytological diagnosis. However, clinicians with an interest…mehr
Diagnostic and exfoliative cytology has today achieved a status that few could have envisaged 20 years ago. While exfoliative cytology has long been employed in gynecological diagnosis, new and rewarding spheres have now developed in which cytological diagnosis plays an important role. Exfoliative cytology, for example, is widely employed as an aid in the continuous assessment of urinary tract tumors, and aspiration cytology in the diagnosis of thyroid dis eases. This has given rise to a growing demand for pathologists experienced in cytological diagnosis. However, clinicians with an interest in morphology were often the first to adopt these simple and safe methods, being naturally attracted by the chance to avoid conducting biopsy, which, in the last analysis, is nothing less than a surgical operation. In this Atlas of Prostatic Cytology Leistenschneider and Nagel expertly demonstrate what can be achieved when clinicians skilled in morphology take an interest in cytological methods. Not only do they have direct contact with the patient, but they also profit from immediately being in a position to assess the results of their diagnostic procedures by examining the specimen obtained. From the technical point of view aspiration biopsy of the prostate is by no means a simple procedure and the difficulties involved would seem to have been underestimated in the initial phase of enthusiastic acclaim. Consequently it has been not unusual for clinicians and pathologists to be disappointed by the high rate of unsatisfactory samples obtained by this method.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
1 The Technical Bases of Aspiration Biopsy.- 1.1 Preparation and Positioning of the Patient.- 1.2 Lubricants and Anesthesia.- 1.3 Instrumentarium for Aspriation.- 1.4 Technique of Aspiration.- 1.5 Acquisition of Suitable Cellular Material.- 1.6 Macroscopic Evaluation of the Aspirate in Biopsy Smears.- 1.7 Smear Technique.- 1.8 Fixation.- 1.9 Shipment of Smears.- 1.10. Complications.- 1.11 Prophylaxis Against Infection.- 1.12 Staining Procedures.- 2 Cytological Microscopy.- 2.1 Microscope.- 2.2 Brightfield Microscopy.- 2.3 Fluorescence Microscopy.- 2.4 Guidelines for Brightfield Microscopy.- 2.5 Procedure.- 3 Normal Findings.- 3.1 Individual Cells, Sheets of Cells and Background.- 3.2 Nuclei.- 4 Atypia.- 4.1 Classification According to Papanicolaou.- 4.2 Atypical Hyperplasia.- 5 Secondary Findings.- 5.1 Erythrocytes.- 5.2 Seminal Vesicle Epithelial Cells.- 5.3 Epithelial Cells of Rectal Mucosa.- 5.4 Urothelial Cells.- 5.5 Metaplastic Squamous Epithelial Cells.- 5.6 Sheets of Keratin.- 5.7 Histiocytic Giant Cells.- 5.8 Intracytoplasmic Granules.- 6 Artefacts.- 7 Primary Diagnosis of Carcinoma.- 7.1 Procedural Reliability.- 7.2 Cytological Criteria for Prostatic Carcinoma.- 8 Grading of Prostatic Carcinoma.- 8.1 Histology.- 8.2 Cytology.- 8.3 Cytological Grading According to the Uropathological Study Group on 'Prostatic Carcinoma'.- 9 Treatment Control by Means of Regression Grading.- 9.1 Cytological Signs of Regression.- 9.2 Cytological Regression Grading.- 9.3 Reproducibility.- 9.4 Clinical Significance of Cytological Regression Grading.- 9.5 Validity of Cytological Regression Grading.- 9.6 Signs of Regression After Initiation of Treatment.- 9.7 Cytological Regression Grading and Findings at Palpation.- 10 Sarcomas.- 11 Secondary Tumors of the Prostate.- 11.1Cytomorphological Criteria.- 12 Prostatitis.- 12.1 Classification.- 12.2 Diagnostic Reliability.- 12.3 Clinical Significance and Complications.- 12.4 General Cytological Criteria of Prostatitis.- 12.5 Summary.- 13 DNA Cytophotometry.- 13.1 Feulgen's Reaction.- 13.2 Single-cell Scanning Cytophotometry.- 13.3 Flow-through Cytophotometry.- 13.4 New Developments in Automatic Cytodiagnosis.- 14 Results of Measurement of Nuclear DNA by Single-cell Scanning Cytophotometry in Prostatic Carcinoma.- 14.1 Well Differentiated Carcinoma (Grade I).- 14.2 Moderately Differentiated Carcinoma (Grade II).- 14.3 Undifferentiated Carcinoma (Grade III).- 14.4 Our own Results with Nuclear DNA Analysis by Single-cell Cytophotometry in Treated Prostatic Carcinoma.- 14.5 The Importance of DNA Cytophotometry in the Treatment of Prostatic Carcinoma.- References.
1 The Technical Bases of Aspiration Biopsy.- 1.1 Preparation and Positioning of the Patient.- 1.2 Lubricants and Anesthesia.- 1.3 Instrumentarium for Aspriation.- 1.4 Technique of Aspiration.- 1.5 Acquisition of Suitable Cellular Material.- 1.6 Macroscopic Evaluation of the Aspirate in Biopsy Smears.- 1.7 Smear Technique.- 1.8 Fixation.- 1.9 Shipment of Smears.- 1.10. Complications.- 1.11 Prophylaxis Against Infection.- 1.12 Staining Procedures.- 2 Cytological Microscopy.- 2.1 Microscope.- 2.2 Brightfield Microscopy.- 2.3 Fluorescence Microscopy.- 2.4 Guidelines for Brightfield Microscopy.- 2.5 Procedure.- 3 Normal Findings.- 3.1 Individual Cells, Sheets of Cells and Background.- 3.2 Nuclei.- 4 Atypia.- 4.1 Classification According to Papanicolaou.- 4.2 Atypical Hyperplasia.- 5 Secondary Findings.- 5.1 Erythrocytes.- 5.2 Seminal Vesicle Epithelial Cells.- 5.3 Epithelial Cells of Rectal Mucosa.- 5.4 Urothelial Cells.- 5.5 Metaplastic Squamous Epithelial Cells.- 5.6 Sheets of Keratin.- 5.7 Histiocytic Giant Cells.- 5.8 Intracytoplasmic Granules.- 6 Artefacts.- 7 Primary Diagnosis of Carcinoma.- 7.1 Procedural Reliability.- 7.2 Cytological Criteria for Prostatic Carcinoma.- 8 Grading of Prostatic Carcinoma.- 8.1 Histology.- 8.2 Cytology.- 8.3 Cytological Grading According to the Uropathological Study Group on 'Prostatic Carcinoma'.- 9 Treatment Control by Means of Regression Grading.- 9.1 Cytological Signs of Regression.- 9.2 Cytological Regression Grading.- 9.3 Reproducibility.- 9.4 Clinical Significance of Cytological Regression Grading.- 9.5 Validity of Cytological Regression Grading.- 9.6 Signs of Regression After Initiation of Treatment.- 9.7 Cytological Regression Grading and Findings at Palpation.- 10 Sarcomas.- 11 Secondary Tumors of the Prostate.- 11.1Cytomorphological Criteria.- 12 Prostatitis.- 12.1 Classification.- 12.2 Diagnostic Reliability.- 12.3 Clinical Significance and Complications.- 12.4 General Cytological Criteria of Prostatitis.- 12.5 Summary.- 13 DNA Cytophotometry.- 13.1 Feulgen's Reaction.- 13.2 Single-cell Scanning Cytophotometry.- 13.3 Flow-through Cytophotometry.- 13.4 New Developments in Automatic Cytodiagnosis.- 14 Results of Measurement of Nuclear DNA by Single-cell Scanning Cytophotometry in Prostatic Carcinoma.- 14.1 Well Differentiated Carcinoma (Grade I).- 14.2 Moderately Differentiated Carcinoma (Grade II).- 14.3 Undifferentiated Carcinoma (Grade III).- 14.4 Our own Results with Nuclear DNA Analysis by Single-cell Cytophotometry in Treated Prostatic Carcinoma.- 14.5 The Importance of DNA Cytophotometry in the Treatment of Prostatic Carcinoma.- References.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826